Healthcare focus Linden Capital Partners specializes exclusively in healthcare and life sciences, presenting cross-sell opportunities with portfolio companies in medical products, specialty distribution, pharmaceutical services, and life sciences services.

Strategic exits Recent exit activity, such as ArtesRx acquisition by Linden, signals an active BI and exit readiness stance; use this to position add-on acquisitions or growth capital to portfolio companies pursuing scale through strategic buyers.

Structured capital New leadership in Linden’s Structured Capital Fund and the hiring of Elizabeth Ko as Co-Head indicate a push into credit-oriented financing solutions; identify mid-market healthcare platforms that could benefit from flexible debt/equity structures.

Mid-market focus Linden targets middle-market platforms across medical products, specialty distribution, pharmaceutical, and services; align value propositions around scalable healthcare platforms with proven revenue traction and potential operational improvements.

Portfolio growth Active portfolio moves, board appointments, and acquisitions in 2025–2026 (e.g., LifeStyles Healthcare connection; Agape Health Group) suggest proactive growth initiatives; present partnerships for add-ons, bolt-ons, and platform-level expansions.